APOA1 and coronary artery disorder: The latter’s suggests that the peroxisome proliferator-activated receptor (PPAR) signalling pathway is perturbed in CAD through an association with APOA1, FABP1 (PPARA), ADIPOQ and RETN (PPARG) (Fig 6).